BR112019000291A2 - processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel - Google Patents

processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel

Info

Publication number
BR112019000291A2
BR112019000291A2 BR112019000291A BR112019000291A BR112019000291A2 BR 112019000291 A2 BR112019000291 A2 BR 112019000291A2 BR 112019000291 A BR112019000291 A BR 112019000291A BR 112019000291 A BR112019000291 A BR 112019000291A BR 112019000291 A2 BR112019000291 A2 BR 112019000291A2
Authority
BR
Brazil
Prior art keywords
preparation
enhancers
guanylate cyclase
soluble guanylate
processes
Prior art date
Application number
BR112019000291A
Other languages
English (en)
Portuguese (pt)
Inventor
Vishnu Vardhan Reddy Karnati
Robert C Livingston
Song Xue
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of BR112019000291A2 publication Critical patent/BR112019000291A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BR112019000291A 2016-07-07 2017-07-06 processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel BR112019000291A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662359453P 2016-07-07 2016-07-07
PCT/US2017/040810 WO2018009597A1 (en) 2016-07-07 2017-07-06 Novel processes for preparation of soluble guanylate cyclase stimulators

Publications (1)

Publication Number Publication Date
BR112019000291A2 true BR112019000291A2 (pt) 2019-04-16

Family

ID=59416789

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019000291A BR112019000291A2 (pt) 2016-07-07 2017-07-06 processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel

Country Status (16)

Country Link
US (3) US11319308B2 (enExample)
EP (2) EP3481818B1 (enExample)
JP (1) JP7112384B2 (enExample)
KR (1) KR102487872B1 (enExample)
CN (1) CN109563077A (enExample)
AU (1) AU2017291827B2 (enExample)
BR (1) BR112019000291A2 (enExample)
CA (1) CA3029375A1 (enExample)
CL (2) CL2019000016A1 (enExample)
EA (1) EA201990237A1 (enExample)
ES (1) ES2963563T3 (enExample)
IL (1) IL263995B (enExample)
MA (1) MA45603A (enExample)
MX (2) MX389920B (enExample)
SG (1) SG11201900096QA (enExample)
WO (1) WO2018009597A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX382762B (es) 2016-07-07 2025-03-13 Cyclerion Therapeutics Inc Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble.
AU2017291827B2 (en) 2016-07-07 2021-10-21 Cyclerion Therapeutics, Inc. Novel processes for preparation of soluble guanylate cyclase stimulators
EP4570797A3 (en) 2018-01-10 2025-09-03 Cyclerion Therapeutics, Inc. Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators
WO2019161534A1 (en) * 2018-02-22 2019-08-29 Ironwood Pharmaceuticals, Inc. Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011150156A2 (en) * 2010-05-26 2011-12-01 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
JP5860459B2 (ja) 2010-06-30 2016-02-16 アイアンウッド ファーマシューティカルズ インコーポレイテッド sGC刺激薬
US9139564B2 (en) * 2011-12-27 2015-09-22 Ironwood Pharmaceuticals, Inc. 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
EP2897953B8 (en) * 2012-09-19 2019-06-26 Cyclerion Therapeutics, Inc. Sgc stimulators
RS59981B1 (sr) * 2013-03-15 2020-03-31 Cyclerion Therapeutics Inc Sgc stimulatori
US20160311826A1 (en) * 2013-12-11 2016-10-27 Ironwood Pharmaceuticals, Inc. Sgc stimulators
US20170298055A1 (en) * 2014-09-17 2017-10-19 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
AU2015317824A1 (en) * 2014-09-17 2017-03-23 Cyclerion Therapeutics, Inc. Pyrazole derivatives as sGC stimulators
KR20170055531A (ko) * 2014-09-17 2017-05-19 아이언우드 파마슈티컬스, 인코포레이티드 에스지씨 자극제
US10844064B2 (en) * 2014-09-17 2020-11-24 Cyclerion Therapeutics, Inc. sGC stimulators
EP3383372B1 (en) * 2015-11-30 2023-11-01 Cyclerion Therapeutics, Inc. Solid dispersions comprising a sgc stimulator
MX382762B (es) 2016-07-07 2025-03-13 Cyclerion Therapeutics Inc Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble.
JP2019524710A (ja) * 2016-07-07 2019-09-05 アイアンウッド ファーマシューティカルズ インコーポレイテッド Sgc刺激剤の固体形態
AU2017291827B2 (en) 2016-07-07 2021-10-21 Cyclerion Therapeutics, Inc. Novel processes for preparation of soluble guanylate cyclase stimulators
EA202091502A1 (ru) * 2017-12-19 2020-11-12 Сайклерион Терапьютикс, Инк. СТИМУЛЯТОРЫ sGC
EP4570797A3 (en) * 2018-01-10 2025-09-03 Cyclerion Therapeutics, Inc. Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators

Also Published As

Publication number Publication date
AU2017291827A1 (en) 2019-02-07
SG11201900096QA (en) 2019-02-27
IL263995A (en) 2019-02-28
KR20190025986A (ko) 2019-03-12
CL2019000016A1 (es) 2019-05-03
WO2018009597A1 (en) 2018-01-11
CA3029375A1 (en) 2018-01-11
MA45603A (fr) 2019-05-15
CL2023000228A1 (es) 2023-09-29
US11773089B2 (en) 2023-10-03
US20240059684A1 (en) 2024-02-22
MX2022001495A (es) 2022-03-11
AU2017291827B2 (en) 2021-10-21
CN109563077A (zh) 2019-04-02
JP7112384B2 (ja) 2022-08-03
EP4249488A3 (en) 2023-12-20
MX389920B (es) 2025-03-20
EP3481818C0 (en) 2023-09-06
EP4249488A2 (en) 2023-09-27
US20220227748A1 (en) 2022-07-21
US11319308B2 (en) 2022-05-03
EA201990237A1 (ru) 2019-08-30
EP3481818B1 (en) 2023-09-06
IL263995B (en) 2021-02-28
EP3481818A1 (en) 2019-05-15
US20210323951A1 (en) 2021-10-21
ES2963563T3 (es) 2024-03-27
NZ750123A (en) 2025-02-28
MX2019000105A (es) 2019-04-22
JP2019525913A (ja) 2019-09-12
KR102487872B1 (ko) 2023-01-12

Similar Documents

Publication Publication Date Title
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
BR112019000291A2 (pt) processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel
WO2013184480A3 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
BR112019000292A2 (pt) processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel
MX2023000044A (es) Nuevos procesos e intermediarios para la preparacion de estimulantes de guanilato ciclasa soluble.
AR117002A2 (es) Proceso para la preparación de inhibidores de quinasa c-fms
BR112022006052A2 (pt) Processo para a preparação de protioconazol
MX377644B (es) 6.7.beta-epóxidos esteroideos como intermedios químicos.
JOP20190265A1 (ar) طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول
AR118647A1 (es) Proceso de preparación de 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-deoxi-1-metilamino-d-glucitol
UA111868C2 (uk) Спосіб одержання естерів (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)-оцтової кислоти
MX378594B (es) Procedimiento e intermedios para la 6,7-alfa-epoxidacion de 4,6-dienos esteroideos
JOP20190264A1 (ar) طريقة لتحضير مركب وسيط من مشتق 4 - ميثوكسي بيرول
BR112018014534A2 (pt) método e intermediário para a preparação de tulatromicina
BR112012013582A2 (pt) processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos
BR112017017066A2 (pt) método de preparação para praziquantel e compostos intermediários do mesmo
CU24518B1 (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina
EA202191158A1 (ru) Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида
MX386842B (es) Proceso para preparar 1-(3,5-diclorofenil)-2,2,2-trifluoroetanona y sus derivados.
MX2023004650A (es) Un procedimiento para la preparacion de clorantraniliprol.
EA202091664A1 (ru) Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы
MX2017009839A (es) Proceso para la produccion de derivados de imidazolo condensados.
BR112021020407A2 (pt) Processo para preparação de intermediários para as sínteses de derivados de vitamina a de polienos por ciclização
PL400932A1 (pl) Nowe pochodne pirolu i sposób ich otrzymywania

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CYCLERION THERAPEUTICS, INC. (US)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]